XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update.
XTL Biopharmaceuticals Ltd. has successfully regained compliance with Nasdaq’s minimum bid price requirement, maintaining a closing bid price of at least $1.00 for over 10 consecutive business days. The notice from Nasdaq has formally acknowledged this achievement, thereby closing the matter regarding the company’s previous non-compliance that was identified in October 2023.
For further insights into XTLB stock, check out TipRanks’ Stock Analysis page.
